Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
News-Medical.Net on MSN
UVA researcher wins $700,000 for promising ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback